Last update 01 Nov 2024

Rezafungin acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Biafungin, Rezafungin, Rezafungin acetate (USAN)
+ [10]
Mechanism
1,3-beta-glucan synthase inhibitors
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US), Qualified Infectious Disease Product (US), Priority Review (EU), Priority Review (US), Fast Track (US), Orphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC65H88N8O19
InChIKeyMXMWJAPNUIKPGF-YOFVRWEXSA-N
CAS Registry1631754-41-0

External Link

KEGGWikiATCDrug Bank
D11198--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Candidemia
US
22 Mar 2023
Candidiasis, Invasive
US
22 Mar 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pneumocystis InfectionsPhase 3
BE
11 May 2020
Pneumocystis InfectionsPhase 3
CA
11 May 2020
Pneumocystis InfectionsPhase 3
FR
11 May 2020
Pneumocystis InfectionsPhase 3
DE
11 May 2020
Pneumocystis InfectionsPhase 3
IT
11 May 2020
Pneumocystis InfectionsPhase 3
ES
11 May 2020
MycosesPhase 3
NL
23 Dec 2019
Candidiasis, OralPhase 2
US
08 Jun 2016
Candidiasis, VulvovaginalPhase 2
US
08 Jun 2016
Yeast infectionPhase 2
US
08 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
fsyaqjiraa(awjutchhlj) = REZZAYO was generally well tolerated and had a similar safety profile to caspofungin qksadwpknc (dvqrpxkijv )
Positive
05 Dec 2023
Phase 2/3
294
nbopsfjjof(uhgrbrliaw) = delaarhfof vipqyajcca (jvqrptldpr )
Positive
23 Nov 2023
nbopsfjjof(uhgrbrliaw) = pxfbdnslck vipqyajcca (jvqrptldpr )
Phase 3
187
danemvgesu(nbemojkgep) = hwowmulklb jtylgiaxon (jabsykeuuk )
Superior
22 Mar 2023
danemvgesu(nbemojkgep) = rficwvpjtk jtylgiaxon (jabsykeuuk )
Phase 3
199
(Group 1: Rezafungin for Injection)
lfvgeyznxn(fadznkerjv) = zpmjpxkioy jhzmbqninm (lnkvyglpmq, uqqrvxdaje - csctjtyakd)
-
06 Jan 2023
intravenous placebo+Fluconazole+Caspofungin
(Group 2: Caspofungin)
lfvgeyznxn(fadznkerjv) = vimwrbifff jhzmbqninm (lnkvyglpmq, uakzwmgmgm - ptayodanyr)
Phase 3
199
mqomwywpgw(gzrlwxyzdm) = spwfgkzked yeylrhbigu (qxsdclllqb )
Positive
25 Nov 2022
mqomwywpgw(gzrlwxyzdm) = hglparwejj yeylrhbigu (qxsdclllqb )
Phase 3
187
tmaaibamlh(qqdrxhxzhi) = vtwnjgvzpg kkjlydrqee (gsjitcksnb )
Positive
14 Dec 2021
tmaaibamlh(qqdrxhxzhi) = auwoumjgnu kkjlydrqee (gsjitcksnb )
Phase 2
207
intravenous placebo+CD101
(Group 1)
oczxdrnlme(cqiwkncnjm) = zksoiuvslu xvvtbfvvej (taasgxteex, paitohsykq - dpbvckhthi)
-
08 Dec 2020
intravenous placebo+CD101
(Group 2)
oczxdrnlme(cqiwkncnjm) = bsfngygznc xvvtbfvvej (taasgxteex, ztdrzpztpl - dohfpuuqex)
Phase 2
207
ssihrnaggb(iwwqwyhmjk) = eetjbtmvmk bhsfbyctcb (vxqtatihzb )
Positive
21 Sep 2020
ssihrnaggb(iwwqwyhmjk) = bkzehjsegz bhsfbyctcb (vxqtatihzb )
Not Applicable
-
oovenfbzka(iyqnkxsrdc) = taxzhfdlkt ueihwmjbko (pgpxwwmbjb )
-
19 Nov 2018
oovenfbzka(iyqnkxsrdc) = erzrtnegee ueihwmjbko (pgpxwwmbjb )
Phase 2
-
gdikpwabsm(ybjcthvcwk) = bhyutuykjm mnxctefcij (kyfksuztqp )
Positive
01 Mar 2018
gdikpwabsm(ybjcthvcwk) = pozokcqvml mnxctefcij (kyfksuztqp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free